-
公开(公告)号:ZA8400438B
公开(公告)日:1984-09-26
申请号:ZA8400438
申请日:1984-01-20
Applicant: BASF AG
Inventor: ROSSY PHILIP A , THYES MARCO , FRANKE ALBRECHT , KOENIG HORST , LEHMANN HANS DIETER , GRIES JOSEF , LUDWIG FRIEDRICH , LENKE D
IPC: A61K31/50 , A61K31/502 , A61K31/535 , A61K31/55 , A61P1/04 , A61P7/02 , A61P9/12 , C07D237/04 , C07D237/14 , C07D237/26 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/14 , C07D413/12 , C07D417/14 , C07D521/00 , A61K , C07D
CPC classification number: C07D231/12 , C07D233/56 , C07D237/04 , C07D237/14 , C07D237/26 , C07D249/08 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D413/12
-
公开(公告)号:YU6680A
公开(公告)日:1983-02-28
申请号:YU6680
申请日:1980-01-11
Applicant: BASF AG
Inventor: TREIBER H , LENKE D , WORSTMANN W
IPC: A61K31/55 , A61K31/553 , A61P25/04 , C07D267/10 , C07D267/22 , A61K31/33
Abstract: Novel hexahydro-1,4-oxazepines of the general formula I I where R1 is hydrogen, or alkyl or acyl each of 1 to 4 carbon atoms, R2 is alkyl of 1 to 4 carbon atoms and R3 and R4 are identical or different and each is hydrogen or methyl, and their salts with physiologically acceptable acids, processes for their preparation, drugs which contain these compounds, and their use in therapy. The compounds may be used for the pharmacotherapy of pain of various geneses.
-
3.
公开(公告)号:YU279579A
公开(公告)日:1983-02-28
申请号:YU279579
申请日:1979-11-14
Applicant: BASF AG
IPC: A61K31/55 , C07D223/16 , C07D405/12
-
4.
公开(公告)号:ZA8101904B
公开(公告)日:1982-05-26
申请号:ZA8101904
申请日:1981-03-23
Applicant: BASF AG
Inventor: MAY H , LENKE D , GRIES J , TESCHENDORF H , WORSTMANN W
IPC: C07D409/06 , A61K31/415 , A61K31/465 , A61K31/47 , A61P9/08 , A61P9/10 , A61P9/12 , A61P43/00 , C07D233/54 , C07D401/06 , C07D403/06 , C07D405/06 , C07D413/06 , C07D417/06 , A61K , C07D
CPC classification number: C07D233/64
-
公开(公告)号:ZA81927B
公开(公告)日:1982-03-31
申请号:ZA81927
申请日:1981-02-12
Applicant: BASF AG
IPC: A61K31/495 , A61K31/496 , C07D413/12 , A61P9/12 , C07D271/10 , C07D405/12 , C07D , A61K
Abstract: Novel phenylpiperazinylpropanols of 1,3,4-oxadiazolylphenols and their physiologically tolerated addition salts with acids, processes for their preparation, and pharmaceutical formulations which contain these compounds and are useful in the treatment of hypertonia.
-
公开(公告)号:DK430380A
公开(公告)日:1981-04-14
申请号:DK430380
申请日:1980-10-10
Applicant: BASF AG
Inventor: FRICKEL F F , FRANKE A , PHILIPSBORN G V , MUELLER C D , LENKE D
IPC: A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4427 , A61K31/445 , A61K31/454 , A61K31/47 , A61P9/00 , A61P9/06 , C07C271/22 , C07D207/34 , C07D207/36 , C07D209/42 , C07D401/12 , C07D401/14 , C07D
Abstract: Substituted piperidinoalkyl ethers of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters and their physiologically tolerated addition salts with acids, processes for their preparation and pharmaceutical formulations which contain these compounds and are useful in the treatment of cardiac arrhythmias.
-
公开(公告)号:ZA792025B
公开(公告)日:1980-06-25
申请号:ZA792025
申请日:1979-04-27
Applicant: BASF AG
Abstract: Alkylamino-propanol derivatives of 3-alkyl-5-(2-hydroxystyryl)-isoxazole, of the general formula where R is hydrogen, alkyl of 1 to 8 carbon atoms, which is unsubstituted or substituted by hydroxyl, alkoxy of 1 to 3 carbon atoms or cycloalkyl with 3 to 8 carbon atoms in the ring, alkenyl or alkynyl of 2 to 8 carbon atoms, or cycloalkyl with 3 to 8 carbon atoms in the ring, the cycloalkyl rings being unsubstituted or mono- or di-substituted by alkyl of 1 to 3 carbon atoms, and R' is alkyl of 1 to 4 carbon atoms, and their addition salts with physiologically acceptable acids, their preparation, and pharmaceutical formulations which contain these compounds and which can be used as valuable drugs in the treatment of hypertonia, coronary diseases of the heart and cardiac arrhythmias.
-
公开(公告)号:DK272080A
公开(公告)日:1980-06-25
申请号:DK272080
申请日:1980-06-25
Applicant: BASF AG
Inventor: TREIBER H J , LENKE D , WORSTMANN W
IPC: A61K31/55 , A61K31/553 , A61P25/04 , C07D267/00 , C07D267/12 , C07D267/14 , C07D
Abstract: PCT No. PCT/EP79/00080 Sec. 371 Date Jun. 26, 1980 Sec. 102(e) Date Jun. 16, 1980 PCT Filed Oct. 22, 1979 PCT Pub. No. WO80/00838 PCT Pub. Date May 1, 1980. The invention relates to novel 1,4-cycloalkano-oxazepines of the general formula where R1 is hydrogen, hydroxyl or alkoxy or acyloxy of 1 to 4 carbon atoms, R2 is a hydrocarbon radical of 1 to 3 carbon atoms, n is 1, 2 or 3 and x is 0 or 1, and of its salts with physiologically acceptable acids; processes for their preparation, and their use in therapy. The novel substances are suitable for the pharmacotherapy of pains of various origins.
-
公开(公告)号:ZA781552B
公开(公告)日:1979-04-25
申请号:ZA781552
申请日:1978-03-16
Applicant: BASF AG
Inventor: LENKE D , PHILIPSBORN G , BOELL W
IPC: A61C8/00 , A61K31/435 , A61K31/44 , A61K31/4406 , A61K31/4415 , A61K31/4418 , A61K31/4427 , A61K31/445 , A61K31/455 , A61K31/495 , A61K31/496 , A61P9/00 , A61P9/04 , A61P9/06 , C07D213/127 , C07D213/65 , C07D213/66 , C07D213/67 , C07D213/79 , C07D213/80 , C07D221/04 , C07D263/32 , C07D401/12 , C07D471/04 , C07D491/04 , C07D491/048 , C07D491/056
Abstract: New pyridinyl aminoalkyl ethers, their N-oxides and their physiologically acceptable addition salts with acids, processes for their preparation and pharmaceutical formulations which contain these compounds and are useful in the treatment of cardiac arrhythmias.
-
公开(公告)号:SE7802927L
公开(公告)日:1978-09-18
申请号:SE7802927
申请日:1978-03-14
Applicant: BASF AG
Inventor: VON PHILIPSBORN G , BOELL W , LENKE D
IPC: A61C8/00 , A61K31/435 , A61K31/44 , A61K31/4406 , A61K31/4415 , A61K31/4418 , A61K31/4427 , A61K31/445 , A61K31/455 , A61K31/495 , A61K31/496 , A61P9/00 , A61P9/04 , A61P9/06 , C07D213/127 , C07D213/65 , C07D213/66 , C07D213/67 , C07D213/79 , C07D213/80 , C07D221/04 , C07D263/32 , C07D401/12 , C07D471/04 , C07D491/04 , C07D491/048 , C07D491/056
Abstract: New pyridinyl aminoalkyl ethers, their N-oxides and their physiologically acceptable addition salts with acids, processes for their preparation and pharmaceutical formulations which contain these compounds and are useful in the treatment of cardiac arrhythmias.
-
-
-
-
-
-
-
-
-